Abeona Therapeutics, Inc. (ABEO)
2.445
-0.28
(-10.44%)
USD |
NASDAQ |
Nov 19, 16:00
2.44
0.00 (0.00%)
After-Hours: 20:00
Abeona Therapeutics Price : 2.445 for Nov. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 2.58 | 2.78 | 2.58 | 2.73 | 1.706M |
| Nov 17, 2026 | 2.60 | 2.625 | 2.49 | 2.60 | 1.710M |
| Nov 16, 2026 | 2.445 | 2.62 | 2.36 | 2.60 | 2.536M |
| Nov 13, 2026 | 2.325 | 2.435 | 2.09 | 2.42 | 3.176M |
| Nov 12, 2026 | 2.28 | 2.35 | 2.22 | 2.29 | 2.417M |
| Nov 11, 2026 | 2.45 | 2.498 | 2.24 | 2.30 | 6.419M |
| Nov 10, 2026 | 2.64 | 2.66 | 2.39 | 2.455 | 3.641M |
| Nov 09, 2026 | 3.62 | 3.62 | 2.30 | 2.54 | 13.57M |
| Nov 06, 2026 | 4.02 | 4.265 | 3.95 | 4.17 | 1.050M |
| Nov 05, 2026 | 4.19 | 4.25 | 3.91 | 3.91 | 1.547M |
| Nov 04, 2026 | 4.36 | 4.42 | 4.19 | 4.22 | 881735.0 |
| Nov 03, 2026 | 4.27 | 4.400 | 4.20 | 4.25 | 1.123M |
| Nov 02, 2026 | 4.43 | 4.456 | 4.16 | 4.25 | 1.012M |
| Oct 30, 2026 | 4.50 | 4.53 | 4.305 | 4.35 | 783431.0 |
| Oct 29, 2026 | 4.54 | 4.73 | 4.470 | 4.56 | 874334.0 |
| Oct 28, 2026 | 4.46 | 4.58 | 4.44 | 4.55 | 618146.0 |
| Oct 27, 2026 | 4.33 | 4.495 | 4.30 | 4.45 | 663678.0 |
| Oct 26, 2026 | 4.39 | 4.41 | 4.305 | 4.31 | 426579.0 |
| Oct 23, 2026 | 4.42 | 4.435 | 4.29 | 4.40 | 797294.0 |
| Oct 22, 2026 | 4.46 | 4.61 | 4.38 | 4.47 | 717808.0 |
| Oct 21, 2026 | 4.62 | 4.67 | 4.50 | 4.51 | 643558.0 |
| Oct 20, 2026 | 4.43 | 4.645 | 4.40 | 4.60 | 1.394M |
| Oct 19, 2026 | 4.47 | 4.49 | 4.32 | 4.41 | 986053.0 |
| Oct 16, 2026 | 4.66 | 4.66 | 4.39 | 4.43 | 819512.0 |
| Oct 15, 2026 | 4.39 | 4.785 | 4.35 | 4.65 | 1.377M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ultragenyx Pharmaceutical, Inc. | 17.21 |
| ACADIA Pharmaceuticals, Inc. | 17.59 |
| Alnylam Pharmaceuticals, Inc. | 147.82 |
| Anika Therapeutics, Inc. | 13.29 |
| Savara, Inc. | 5.205 |
Price Related Metrics
| PS Ratio | 3.550 |
| Price to Book Value | 1.110 |
| Earnings Yield | -45.41% |
| Market Cap | 139.78M |